Influence
July 16, 2020

Regenstrief research scientist shares ICU experience during Side Effects COVID-19 panel

Regenstrief research scientist Sikandar Khan, D.O., shared his perspective from working in the intensive care unit (ICU) in the midst of the COVID-19 outbreak during a panel hosted by Side Effects Public Media and Indiana Public Broadcasting.

Dr. Khan has been treating patients in the ICU at Indiana University Health Methodist Hospital throughout the COVID-19 pandemic. He spoke about how data has helped guide decisions in the ICU, allowing clinicians to anticipate surges in cases and plan for equipment and personnel needs.

He also talked about the potentially long recovery COVID-19 survivors face. Patients who need intensive care, especially those who are put on ventilators, are at risk for post intensive care syndrome. This can affect the patient’s body as well as the mind. Dr. Khan said he and his colleagues are closely watching to see what recovery will look like for COVID-19 patients.

Dr. Khan also lauded his colleagues for adapting to the stressful situation and their tireless work to take care of patients. He urged everyone to continue taking precautions, including social distancing and wearing masks.

Watch the entire panel here

Related News

Malaz Boustani, M.D., MPH, Paul Dexter, M.D., Zina Ben Miled, PhD, M.S.

Dementia risk prediction: Zero-minute assessment at less than a dollar cost

Risk detection is important for care management and may alter course of the disease INDIANAPOLIS – A new study

Joshua Vest, PhD, MPH

Regenstrief Institute researcher appointed associate dean for research at IU Indianapolis Fairbanks School of Public Health

Regenstrief Institute Research Scientist Joshua Vest, PhD, MPH, has been appointed associate dean for research at the Indiana University

Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation

Title: Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation Published in the journal JAMA Neurology. Here is

AMIA honors Regenstrief researcher with leadership award

Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, was awarded a 2024 leadership award by the American Medical